Skip to main content
. 2022 Mar 29;9:819753. doi: 10.3389/fnut.2022.819753

Figure 7.

Figure 7

(A) Ligand interaction diagram of Dihydrojoubertiamine (-6.497 Δkcal/mol) in the flumazenil binding site on the GABA-A receptor; (B) Ligand interaction diagram of 4-(3-methoxy-4-hydroxy-phenyl)-4-[2-acetylmethylamino)ethyl]cyclohexadienone (-8.791Δkcal/mol) in the citalopram binding site on the 5-HT receptor; (C) Ligand interaction diagram of Mesembranol (-9.879Δkcal/mol) in the galantamine binding site on the AChE enzyme.